Nanalysis Scientific Corp. (TSXV:NSCI)

Nanalysis Scientific Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.54	0.55	1.38	0.76	3.53	10.41
Cash & Short-Term Investments	0.54	0.55	1.38	0.76	3.53	10.41
Cash Growth	56.98%	-60.39%	81.29%	-78.47%	-66.12%	229.48%
Accounts Receivable	7.02	7.61	10.11	8.35	7.14	4.97
Other Receivables	1.33	0.9	0.96	1.41	1.85	1.13
Receivables	8.35	8.5	11.07	9.76	8.98	6.1
Inventory	4.22	3.65	4.39	5.79	7.39	3.68
Prepaid Expenses	1.06	1.43	1.43	1.6	2.06	0.58
Restricted Cash	-	2.61	-	-	-	-
Total Current Assets	14.17	16.74	18.26	17.91	21.96	20.76
Property, Plant & Equipment	1.7	2.18	2.89	4.74	6.42	2.54
Long-Term Investments	-	-	-	5.73	-	-
Goodwill	5.7	5.7	5.7	5.7	13.08	0.39
Other Intangible Assets	1.89	2	1.92	3.47	3.71	1.62
Long-Term Accounts Receivable	-	0.12	0.34	-	0.77	-
Long-Term Deferred Tax Assets	-	-	-	-	0.1	-
Long-Term Deferred Charges	9.3	10.39	11.12	12.47	22.91	12.48
Other Long-Term Assets	0.86	1.3	2.14	3.11	0.94	-
Total Assets	33.61	38.41	42.37	53.82	69.9	37.79

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	4.8	5.2	5.83	5.08	5.76	4.44
Short-Term Debt	1.58	2.8	2.8	2.9	2.54	-
Current Portion of Long-Term Debt	4.7	6.99	3.22	3.59	1.11	1.94
Current Portion of Leases	0.74	0.78	0.83	0.8	0.79	0.26
Current Unearned Revenue	1.71	1.25	1.19	1.32	1.93	1.8
Other Current Liabilities	0.19	0.18	0.52	0.91	1.38	0.21
Total Current Liabilities	13.72	17.2	14.38	14.6	13.51	8.65
Long-Term Debt	6.5	6.2	10.14	12.56	3.79	2.75
Long-Term Leases	0.44	0.81	1.38	2.13	2.53	1.04
Long-Term Unearned Revenue	0.38	0.55	0.65	0.88	1.12	0.82
Long-Term Deferred Tax Liabilities	0.07	0.08	0.12	0.18	0.26	0.26
Other Long-Term Liabilities	0.16	0.15	0.16	-	1.14	0.32
Total Liabilities	21.27	24.99	26.83	30.34	22.33	13.83

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	60.86	60.2	57.57	53.2	49.02	31.3
Additional Paid-In Capital	6.69	6.46	6	4.67	3.09	1.64
Retained Earnings	-56.21	-54.26	-48.6	-34.99	-18.79	-9.69
Comprehensive Income & Other	1	1.02	0.58	0.6	1.82	0.71
Total Common Equity	12.34	13.42	15.55	23.48	35.13	23.96
Minority Interest	-	-	-	-	12.44	-
Shareholders' Equity	12.34	13.42	15.55	23.48	47.57	23.96
Total Liabilities & Equity	33.61	38.41	42.37	53.82	69.9	37.79

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	13.96	17.58	18.36	21.97	10.75	5.99
Net Cash (Debt)	-13.42	-17.03	-16.99	-21.21	-7.23	4.42
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.11	-0.15	-0.15	-0.21	-0.08	0.06
Filing Date Shares Outstanding	139.41	132.31	113.22	113.03	94.45	77.17
Total Common Shares Outstanding	139.34	132.31	113.22	101.92	94.45	77.17
Working Capital	0.45	-0.46	3.88	3.32	8.45	12.12
Book Value Per Share	0.09	0.10	0.14	0.23	0.37	0.31
Tangible Book Value	4.75	5.73	7.93	14.31	18.33	21.95
Tangible Book Value Per Share	0.03	0.04	0.07	0.14	0.19	0.28
Machinery	4.03	4.01	3.99	3.96	4.61	2.42
Leasehold Improvements	0.61	0.61	0.58	0.59	0.59	0.48

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 27, 2026

Data Sources Report a data error